Author | David J. Kerr, CBE, MD, DSC, FRCP, FMEDSCI

Articles

Capecitabine/Irinotecan Combination Regimens in Colorectal Cancer

April 01, 2002

Capecitabine (Xeloda) and irinotecan (CPT-11, Camptosar) both have demonstrated single-agent activity in patients with colorectal cancer.